GlassScriptPhysician profile
Heather A Jones
NPI 1528354438
$1,561.12
in general payments reported to CMS, 2019-2025
17 companies · $596 in 2025
The $596 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $19.41 · 2022: $283 · 2023: $280 · 2024: $383 · 2025: $596.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,115 · Education: $144.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,114.65 |
| Education | $144.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $708.06 | 2021-2025 | |
| Genzyme Corporation | $157.93 | 2022-2025 | |
| Janssen Biotech, INC. | $152.28 | 2025 | Tremfya |
| Pfizer INC. | $123.02 | 2023-2025 | |
| Novartis Pharmaceuticals Corporation | $106.38 | 2022-2024 | |
| E.R. Squibb & Sons, L.L.C. | $79.60 | 2023-2024 | Sotyktu |
| Regeneron Healthcare Solutions, INC. | $48.01 | 2023 | Dupixent |
| Incyte Corporation | $36.57 | 2022-2024 | Opzelura |
| Dermavant Sciences, INC. | $35.51 | 2023 | Vtama |
| Leo Pharma INC. | $28.84 | 2025 | Adbry |
| Janssen Scientific Affairs, LLC | $25.45 | 2022 | |
| Amgen INC. | $23.03 | 2024 | Otezla |
| Hospira, INC. | $16.24 | 2025 | |
| Galderma Laboratories, L.P. | $13.63 | 2025 | Nemluvio |
| Organon LLC | $6.57 | 2025 | Vtama |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.